Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 3. Association between XRCC1 expression levels and cancer patients' PFS and DSS prognosis, using univariate survival analysis in various cancers. (A) Relevance of XRCC1 gene expression levels to PFS prognosis across cancer types in TCGA dataset. (B) Relevance of XRCC1 gene expression to DSS prognosis across cancer types in TCGA dataset. Red font indicated P-value < 0.05.